Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind Randomised Placebo-controlled Study of Prolardii Gastro-resistant (GR) Caps in the Prevention and Treatment of Antibiotic-associated Diarrhoea.

NCT03256708 is registered in ClinicalTrials.gov with Therabel Pharma SA/NV as lead sponsor.

NCT NCT03256708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03256708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind Randomised Placebo-controlled Study of Prolardii Gastro-resistant (GR) Caps in the Prevention and Treatment of Antibiotic-associated Diarrhoea.
Lead sponsor
Therabel Pharma SA/NV
Phase
Not applicable
Overall status
Unknown status
Start date
October 19, 2017
Completion date
September 30, 2018
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic-associated diarrhea